Egyptian security forces have successfully identified and shut down an unlicensed factory in Giza that was producing medical supplies and cosmetics. This operation was part of ongoing efforts to combat commercial fraud and regulate the market. The factory, located in the 6th of October district of Giza, was discovered through a thorough inspection by the General Administration for Supply and Internal Trade Police.
Upon inspection, authorities found 2 tons of pharmaceutical raw materials of unknown origin inside the factory. Additionally, they discovered 13,000 containers of stimulants, dietary supplements, and cosmetics that were also of unknown origin and in their final packaging form. The presence of these large quantities of unidentified materials raised significant concerns about the potential risks to public health.
The authorities also found nearly 1 million cartons and labels used for packaging and labeling, along with 19 various machines and a production line. These items suggest that the factory was fully equipped to produce and distribute large quantities of products. The materials seized were apparently being prepared for distribution in the market.
The products in question were found to be intended for release into the market, which would have constituted fraud and deception of consumers. The goal of the factory's operations appears to have been to achieve illicit profits. The successful shutdown of the factory is a significant step in protecting public health and preventing the distribution of potentially harmful products.
The General Administration for Supply and Internal Trade Police, part of the Economic Security sector, played a crucial role in this operation. Their efforts are essential in maintaining the integrity of the market and ensuring that products available to consumers meet necessary safety and quality standards.
The legal procedures related to this case have been initiated. The involvement of various security and administrative bodies highlights the comprehensive approach taken by Egyptian authorities to tackle issues related to commercial fraud and public health.
This operation demonstrates the ongoing commitment of Egyptian law enforcement agencies to monitor and regulate industrial activities that impact public health. By taking action against unlicensed and potentially hazardous production facilities, the authorities aim to safeguard consumer interests and maintain market stability.
Key points
- The factory was producing medical supplies and cosmetics without a license.
- Authorities seized 2 tons of unknown origin pharmaceutical raw materials and 13,000 containers of finished products.
- The operation was part of efforts to combat commercial fraud and regulate the market.
